Insider Transactions in Q1 2022 at Marrone Bio Innovations Inc (MBII)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
22,728
-1.01%
|
$22,728
$1.11 P/Share
|
|
Mar 24
2022
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.88%
|
$0
$0.8 P/Share
|
|
Feb 07
2022
|
Suping (Sue) Cheung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,064
+50.0%
|
$0
$0.63 P/Share
|
|
Feb 07
2022
|
Kevin Helash Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
178,831
+42.54%
|
$0
$0.63 P/Share
|
|
Feb 07
2022
|
Timothy B Johnson VP (Field and Technical) |
BUY
Grant, award, or other acquisition
|
Direct |
66,623
+38.78%
|
$0
$0.63 P/Share
|
|
Feb 07
2022
|
Linda V Moore Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
111,039
+45.19%
|
$0
$0.63 P/Share
|
|
Feb 07
2022
|
Keith Pitts SVP & Chief Sust. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,312
+48.93%
|
$0
$0.63 P/Share
|
|
Feb 07
2022
|
Amit Vasavada SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
79,481
+40.08%
|
$0
$0.63 P/Share
|